Dasatinib (BMS-354825), a multi-targeted kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane and activation loop mutant kit isoforms associated with human malignancies

被引：0

作者：

Schittenhelm, MM

Shiraga, S

Schroeder, A

Corbin, AS

Griffith, D

Lee, FY

Deininger, MW

Druker, BJ

Heinrich, MC

机构：

[1] Univ Tubingen, Tubingen, Germany

[2] Oregon Hlth & Sci Univ, Inst Canc, Portland, OR 97201 USA

[3] Portland VA Med Ctr, Portland, OR USA

[4] Bristol Myers Squibb Co, Princeton, NJ 08543 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3358

引用

页码：938A / 939A

页数：2